BOOTS BLOCKED NOSE RELIEF Nasal spray (2019)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
Almus Decongestant Nasal Spray. Boots Blocked Nose Relief 0.05% w/v Nasal Spray.
Qualitative and quantitative composition
Active ingredient %w/v: Oxymetazoline hydrochloride 0.05%.
Pharmaceutical form
Nasal Spray.
Therapeutic indications
For the fast relief of stuffy noses due to head colds and hayfever.
Posology and method of administration
Hold the bottle upright and insert nozzle into nostril. Adults and children over 12 years 1-2 sprays up each nostril every 6-8 hours. Children under 12 years Not to be administered to children under 12 ...
Contraindications
Hypersensitivity to any of the ingredients, patients with cardiovascular disease, hyperthyroidism, angle closure glaucoma or prostatic enlargement.
Special warnings and precautions for use
Keep away from the eyes. Not to be used for children under 12 years without medical advice. The spray should not be used in excess of the stated dosage nor for longer than seven days without medical advice. ...
Interaction with other medicinal products and other forms of interaction
Boots Nasal Spray should not be given to patients being treated with monoamine oxidase inhibitors or within 14 days of ceasing such treatment.
Pregnancy and lactation
The safety of Boots Nasal Spray during pregnancy and lactation has not been established, but is not thought to constitute a hazard during these periods.
Effects on ability to drive and use machines
No adverse effects known.
Undesirable effects
Occasionally may cause local irritation and dryness of the mouth and throat. Prolonged use may cause rebound congestion and rhinitis medicamentosa. Reporting of suspected adverse reactions Reporting suspected ...
Overdose
Overdosage may give rise to local irritation and rebound congestion. Treatment need only be symptomatic.
Pharmacodynamic properties
Oxymetazoline hydrochloride is a sympathomimetic amine having vasoconstrictor properties which are utilised in the relief of nasal congestion.
Pharmacokinetic properties
Oxymetazoline enters tissues rapidly and local vasoconstriction is normally achieved within 5-10 minutes of intranasal administration. The full effect lasts for 5-6 hours and then gradually subsides over ...
Preclinical safety data
There are no preclinical data of relevance to the prescriber which are additional to that already included.
List of excipients
Monosodium phosphate fine cryst Disodium phosphate cryst Methyl hydroxybenzoate Cetrimide Levomenthol natural Or Levomenthol synthetic Camphor racemic Eucalyptol Alcohol 96% Purified water
Incompatibilities
Not applicable.
Shelf life
Shelf life: 18 months.
Special precautions for storage
Do not store above 25°C.
Nature and contents of container
A 22ml polypropylene bottle with a polythene plug and elongated nozzle dip tube fitted with a wadless polythene cap that fits the elongated nozzle.
Special precautions for disposal and other handling
Not applicable.
Marketing authorization holder
The Boots Company PLC, 1 Thane Road West, Nottingham, NG2 3AA Trading as: BCM
Marketing authorization number(s)
PL00014/0292
Date of first authorization / renewal of the authorization
24 July 1989
Date of revision of the text
15 February 2019
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση: